MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

August 06, 2015

In Uzbekistan’s Autonomous Republic of Karakalpakstan, Doctors Without Borders/Médecins Sans Frontières (MSF) runs a tuberculosis (TB) program in collaboration with the Ministry of Health, helping patients manage the side effects of their drug regimens and providing psychosocial support to improve treatment adherence. Here, MSF medical team leader Tetyana Pylypenko discusses MSF’s

December 17, 2013

Tuberculosis (TB) and its drug-resistant forms are a global health threat to which children are particularly vulnerable.

July 11, 2013

MSF doctor Emily Wise blogs from Karakalpakstan, Uzbekistan, where MSF is working to treat tuberculosis patients.

June 25, 2012

People displaced by conflict are fleeing Mali en masse—and settling in places already weakened by food insecurity.

May 11, 2012

Refugees from the West African country of Mali face insufficient levels of assistance in camps rife with disease and malnutrition where the looming rainy season will further complicate the deployment of aid. 

May 11, 2012

Nearly 160,000 Malians have fled their country for camps in Burkina Faso, Mauritania, and Niger. While instability persists in Mali, another threat looms: the rainy season, which will further complicate the deployment of aid.

May 10, 2012

Approximately 56,000 Malians have taken refuge in Burkina Faso after fleeing fighting that began in Mali in mid-January. They are living in makeshift shelters in camps where the sun beats down relentlessly and where aid is severely lacking.

Pages

January 19, 2017

NEW YORK, JANUARY 20, 2017—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) began a new clinical trial this week in Uzbekistan to develop a radically improved course of treatment for drug-resistant tuberculosis (DR-TB).

The trial aims to find a treatment regimen for DR-TB that is drastically shorter, more effective, and causes fewer side effects than the current treatment options.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

August 06, 2015

In Uzbekistan’s Autonomous Republic of Karakalpakstan, Doctors Without Borders/Médecins Sans Frontières (MSF) runs a tuberculosis (TB) program in collaboration with the Ministry of Health, helping patients manage the side effects of their drug regimens and providing psychosocial support to improve treatment adherence. Here, MSF medical team leader Tetyana Pylypenko discusses MSF’s

December 17, 2013

Tuberculosis (TB) and its drug-resistant forms are a global health threat to which children are particularly vulnerable.

July 11, 2013

MSF doctor Emily Wise blogs from Karakalpakstan, Uzbekistan, where MSF is working to treat tuberculosis patients.

June 25, 2012

People displaced by conflict are fleeing Mali en masse—and settling in places already weakened by food insecurity.

May 11, 2012

Refugees from the West African country of Mali face insufficient levels of assistance in camps rife with disease and malnutrition where the looming rainy season will further complicate the deployment of aid. 

May 11, 2012

Nearly 160,000 Malians have fled their country for camps in Burkina Faso, Mauritania, and Niger. While instability persists in Mali, another threat looms: the rainy season, which will further complicate the deployment of aid.

May 10, 2012

Approximately 56,000 Malians have taken refuge in Burkina Faso after fleeing fighting that began in Mali in mid-January. They are living in makeshift shelters in camps where the sun beats down relentlessly and where aid is severely lacking.

Pages